These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13313526)

  • 1. Evaluation of Japanese B encephalitis vaccine. IV. Pattern of serologic response to vaccination over a five-year period in an endemic area (Okayama, Japan).
    TIGERTT WD; BERGE TO; BURNS KF; SATTERWHITE JP
    Am J Hyg; 1956 May; 63(3):238-49. PubMed ID: 13313526
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Japanese B encephalitis vaccine. III. Okayama field trial, 1946-1949.
    ANDO K; SATTERWHITE JP
    Am J Hyg; 1956 May; 63(3):230-7. PubMed ID: 13313525
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Japanese B encephalitis vaccine. II. Serologic response following subcutaneous and intradermal administration.
    MATUMOTO M; KITAOKA M; BURNS KF
    Am J Hyg; 1956 May; 63(3):228-9. PubMed ID: 13313524
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological response to Japanese B encephalitis vaccine of children and horses immune to St. Louis virus.
    HAMMON WM; SATHER GE; LENNETTE EH; REEVES WC
    Proc Soc Exp Biol Med; 1956 Mar; 91(3):517-21. PubMed ID: 13322986
    [No Abstract]   [Full Text] [Related]  

  • 5. Serologic studies of encephalitis in Japan. I. Hemagglutination-inhibiting, complement-fixing, and neutralizing antibody following overt Japanese B encephalitis.
    SOUTHAM CM
    J Infect Dis; 1956; 99(2):155-62. PubMed ID: 13376908
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of attenuated strain of Japanese B encephalitis virus for possible use as a vaccine.
    ROHITAYODHIN S; HAMMON WM
    Mil Med; 1962 Jul; 127():567-8. PubMed ID: 14493409
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic studies of Japanese encephalitis virus in Japan. IV. Maternal antibody in birds.
    BUESCHER EL; SCHERER WF; ROSENBERG MZ; KUTNER LJ; McCLURE HE
    J Immunol; 1959 Dec; 83():614-9. PubMed ID: 13805723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental data on the effectivness of vaccination against Japanese encephalitis].
    LEVKOVICH EN
    Vopr Virusol; 1956; 1(4):39-44. PubMed ID: 13392706
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the problem of the preparation of a tissue culture vaccine against Japanese encephalitis].
    LEVKOVICH EN; ZASUKHINA GD
    Zh Mikrobiol Epidemiol Immunobiol; 1961 May; 32():38-42. PubMed ID: 13761569
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of Japanese B encephalitis vaccine. I. General background and methods.
    SABIN AB; TIGERTT WD
    Am J Hyg; 1956 May; 63(3):217-27. PubMed ID: 13313523
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination.
    Konishi E; Shoda M; Kondo T
    Vaccine; 2004 Mar; 22(9-10):1097-103. PubMed ID: 15003636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic studies of Japanese encephalitis virus in Japan. III. Infection and antibody responses of birds.
    BUESCHER EL; SCHERER WF; ROSENBERG MZ; McCLURE HE
    J Immunol; 1959 Dec; 83():605-13. PubMed ID: 13805724
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic studies of Japanese encephalitis virus in Japan. II. Antibody responses following inapparent human infection.
    SCHERER WF; KITAOKA M; GROSSBERG SE; OKUNO T; OGATA T; CHANOCK RM
    J Immunol; 1959 Dec; 83():594-604. PubMed ID: 14442654
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to intracutaneous and subcutaneous vaccination against Japanese B encephalitis.
    HU HY; LEE PH; SHIH SH
    Chin Med J; 1956; 74(5):489-95. PubMed ID: 13396888
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis vaccine including a preliminary report on dengue fever and Chikungunya vaccines.
    Kitaoka M
    Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():41-56. PubMed ID: 4297905
    [No Abstract]   [Full Text] [Related]  

  • 18. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with complete adjuvant-added inactivated virus vaccine of Japanese encephalitis to swine for preventing viremia (with specific reference to the effect of vaccination on viremia; epidemiological study on Japanese encephalitis. 35).
    Ogata M; Nagao Y; Jitsunari F; Kikui R; Kitamura N
    Acta Med Okayama (1952); 1970; 24(6):579-87. PubMed ID: 4334578
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on mouse brain and chick embryo tissue in connection with the preparation of Japanese encephalitis vaccine.
    ITOH H; KOBAYASHI F; TODA M; TAKASHITA I; KITAGAWA S
    Kitasato Arch Exp Med; 1953 Dec; 26(4):243-58. PubMed ID: 13286895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.